BluMaiden and Perspectum Ltd. (“Perspectum”) Form Strategic Collaboration to Introduce Novel Insights into Clinical Trials [ Read Article + ]
Distinguished Laureate Professor Nick Talley Joins BluMaiden Biosciences as Scientific Advisor [ Read Article + ]
Michael Tillmann Joins BluMaiden Biosciences as Investor and as Appointed Chairman of the Board [ Read Article + ]
